In this issue:
COPD and VTE risk/mortality in a general population
Time trends and case fatality of in-hospital treated PE
Trends in acute PE management and outcomes
Cancer-associated VTE: stopping anticoagulation on cancer cure
Prognostic impact of copeptin in normotensive PE
Antithrombotics for VTE disease
Long-term CTEPH outcomes
Warfarin and PAH survival
BMPR2 mutations and survival in PAH
β-blocker use in PAH
Selexipag improves PAH outcomes
5-year outcomes of REVEAL registry patients
Please login below to download this issue (PDF)